https://doi.org/10.4081/jbr.2011.4659

The frequency of T regulatory cells is increased in peripheral blood of patients with colon-rectal cancer

Vol. 84 No. 1 (2011)
Submitted: August 4, 2014
Accepted: August 4, 2014
Published: January 30, 2011
regulatory T cells, colon-rectal cancer
Abstract Views: 753
PDF: 472
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

D. Saverino
daniele.saverino@unige.it
C. Stabilini
R. SImone
E. Gianetta
F. Milintenda-Florian
Immune system can recognise the tumor-associated antigens present in peripheal blood of cancer patients. Recent studies suggest that CD4+CD25+ regulatory T cells (Treg) might hamper effective immune-surveillance of cancer cells and impede effective immune responses to established tumours. The aim of this study is to demonstrate the presence of Treg in the peripheral blood of colon-rectal cancer (CRC) patients. Results indicate an increase frequency of Treg in the peripheral blood of CRC patients. In addition, Treg is able to regulate the in vitro proliferative response to CEA. Thus, these cells could regulate the immunosuppression and, eventually, the neoplastic progression in CRC patients.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite

Saverino, D., Stabilini, C., SImone, R., Gianetta, E., & Milintenda-Florian, F. (2011). The frequency of T regulatory cells is increased in peripheral blood of patients with colon-rectal cancer. Journal of Biological Research - Bollettino Della Società Italiana Di Biologia Sperimentale, 84(1). https://doi.org/10.4081/jbr.2011.4659

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.